Form 8-K - Current report:
SEC Accession No. 0001437749-25-021738
Filing Date
2025-07-01
Accepted
2025-07-01 16:01:11
Documents
14
Period of Report
2025-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K naii20250701_8k.htm   iXBRL 8-K 22870
2 EXHIBIT 10.68 ex_835763.htm EX-10.68 6104
  Complete submission text file 0001437749-25-021738.txt   160144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA naii-20250627.xsd EX-101.SCH 3578
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE naii-20250627_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE naii-20250627_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE naii-20250627_pre.xml EX-101.PRE 11583
16 EXTRACTED XBRL INSTANCE DOCUMENT naii20250701_8k_htm.xml XML 2847
Mailing Address 1535 FARADAY AVENUE CARLSBAD CA 92008-7319
Business Address 1535 FARADAY AVENUE CARLSBAD CA 92008-7319 7607367700
NATURAL ALTERNATIVES INTERNATIONAL INC (Filer) CIK: 0000787253 (see all company filings)

EIN.: 841007839 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-15701 | Film No.: 251096188
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)